Oxidative stress as a therapeutic target in diabetes: Revisiting the controversy

Diabetes and Metabolism

Volumn 29, Issue 6, 2003, Pages 579-585

  Wiernsperger, N F ^a  

^a INSERM   (France)

Author keywords

Antioxidants; Diabetes; Diabetic Microangiopathy; Insulin Resistance; Oxidative Stress

Indexed keywords

ANTIOXIDANT; FREE RADICAL;

DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DISEASE COURSE; DRUG EFFICACY; INSULIN RESISTANCE; METABOLIC DISORDER; METABOLISM; OXIDATIVE STRESS; REVIEW; VASCULAR DISEASE; VASCULARIZATION;

EID: 0347753692     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70072-1     Document Type: Review

References (82)

1. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signalling pathways: a unifying hypothesis of type 2 diabetes. Endocrine Reviews, 2002, 23, 599-622.
2. Halliwell B, Zhao K, Whiteman M. Nitric oxide and peroxynitrite. The ugly, the uglier and the not so good. Free Rad Res, 1999, 31, 651-69.
3. Hayden MR, Tyagi SC. Islet redox stress: the manifold toxicities of insulin resistance, metabolic syndrome and amylin derived islet amyloid in type 2 diabetes mellitus. JOP 2002, 3, 86-108.
4. Fang YZ, Yang S, Wu G. Free radicals, antioxidants and nutrition. Nutrition, 2002, 18, 872-9.
5. Dröge W. Free radicals in the physiological control of cell function. Physiol Rev, 2001, 82, 47-95.
6. Culotta VC. Superoxide dismutase, oxidative stress, and cell metabolism. Curr Topics Cell Reg, 2000, 36, 117-32.
7. Gort A, Imlay JA. Balance between endogenous superoxide stress and anti-oxidant defenses. J Bacteriol, 1998, 180, 1402-10
8. Nishikawa T, Edelstein D, Du XL, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature, 2000, 404, 787-90.
9. Recchioni R, Marcheselli F, Moroni F, Pieri C. Apoptosis in human aortic endothelial cells induced by hyperglycaemic condition involves mitochondrial depolarisation and is prevented by N-acetyl-L-cysteine. Metabolism, 2002, 51, 1384-8.
10. Yamagishi SI, Edelstein D, Du XL, Brownlee M. Hyperglycemia potentiates collagen-induced platelet activation through mitochondrial superoxide overproduction. Diabetes, 2001, 50, 1491-4.
11. Brodsky SV, Gao S, Li H, Goligorsky MS. Hyperglycemic switch from mitochondrial nitric oxide to superoxide production in endothelial cells. Am J Physiol Heart Circ Physiol, 2002, 283, H2130-9.
12. Wolff SP, Bascal ZA, Hunt JV. Autoxidative glycosylation: free radicals and glycation theory. Prog Clin Biol Res, 1989, 304, 259-75.
13. Kennedy AL, Lyons TJ. Glycation, oxidation and lipoxidation in the development of diabetic complications. Metabolism, 1997, 46, 14-21.
14. Yim MB, Yim HS, Lee C, Kang SO, Chock PB. Protein glycation. Creation of catalytic sites for free radical generation. Ann NY Acad Sci, 2001, 928, 48-53.
15. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications. A new perspective on an old paradigm. Diabetes, 1999, 48, 1-9.
16. Chappey O, Dosquet C, Wautier MP, Wautier JL. Advanced glycation end products, oxidant stress and vascular lesions. Eur J Clin Invest, 1997, 27, 97-108.
17. Kawamura N, Ookawara T, Suzuki K, Konishi K, Mino M, Taniguchi N. Increased glycated Cu, Zn-superoxide dismutase levels in erythrocytes of patients with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab, 1992, 74, 1352-4.
18. Morgan PE, Dean RT, Davies MJ. Inactivation of cellular enzymes by carbonyls and protein-bound glycation/glycoxidation products. Arch Biochem Biophys, 2002, 403, 259-69.
19. Yan H, Harding JJ. Glycation-induced inactivation and loss of antigenicity of catalase and superoxide dismutase. Biochem J, 1997, 328, 599-605.
20. Kaneto H, Fujii J, Suzuki K, et al. DNA cleavage induced by glycation of Cu, Zn-superoxide dismutase. Biochem J, 1994, 304, 219-25.
21. Kashiwagi A, Shinozaki K, Nishio Y, et al. Endothelium-specific activation of NAD(P)H oxidase in aortas of exogenously hyperinsulinemic rats. Am J Physiol Soc, 1999, 277, E976-E983.
22. McCarty MF. Insulin's stimulation of endothelial superoxide generation may reflect up-regulation of isoprenyl transferase activity that promotes rac translocation. Med Hypotheses, 2002, 58, 472-5.
23. Yamagishi SI, Edelstein D, Du SL, Kaneda Y, Guzman M, Brownlee M. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem, 2001, 276, 25096-100.
24. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest, 1993, 91, 2546-51.
25. Inoguchi T, Li P, Umeda F, et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C - dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes, 2000, 49, 1939-45.
26. Boethel CD. Sleep and the endocrine system: new associations to old diseases. Curr Opin Pulm Med, 2002, 8, 502-5.
27. Prabhakar NR. Sleep apneas: an oxidative stress. Am J Respir Crit Care Med, 2002, 165, 859-60.
28. Hogg N, Kalyanaraman B. Nitric oxide and lipid peroxidation. Biochim Biophys Acta, 1991, 1411, 378-84.
29. kB activation, and diabetogenesis. PSEBM, 1999, 222, 205-13.
30. Lenzen S, Drinkgern J, Tiedge M. Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes. Diabetes, 1999, 48, 927-32.
31. Matsuoka T, Kajimoto Y, Watada H. Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells. J Clin Invest, 1997, 99, 144-50.
32. Bottino R, Balamurugan AN, Bertera S, Pietropaolo M, Trucco M, Piganelli JD. Preservation of human islet cell functional mass by antioxidative action of a novel SOD mimic compound. Diabetes, 2002, 51, 2561-7.
33. Sakubara H, Mizukami H, Yagihashi N, Wada R, Hanyu C, Yagihashi S. Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese type 11 diabetic patients. Diabetologia, 2002, 45, 85-96.
34. Bertelsen M, Änggard EE, Carrier MJ. Oxidative stress impairs insulin internalization in endothelial cells in vitro. Diabetologia, 2001, 44, 605-13.
35. Rudich A, Tirosh A, Potashnik R, Hemi R, Kanety H, Bashan N. Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-LI adipocytes. Diabetes, 1998, 47, 1652-69.
36. Lin KT, Xue JY, Nomen M, Spur B, Wong PY. Peroxynitrite-induced apoptosis in HL-69 cells. J Biol Chem, 1995, 270, 16487-90.
37. Brodsky SV, Morrishow AM, Dharia N, Gross SS, Goligorsky MS. Glucose scavenging of nitric oxide. Am J Physiol Renal Physiol, 2001, 280, F480-F486.
38. Renaudin C, Michoud E, Rapin JR, Lagarde M, Wiernsperger N. Hyperglycaemia modifies the reaction of microvessels to insulin in rat skeletal muscle. Diabetologia, 1998, 41, 26-33.
39. Shinozaki K, Kashiwagi A, Nishio Y, et al. Abnormal biopterin metabolism is a major cause of impaired endothelium-dependent relaxation through nitric oxide/O2-imbalance in insulin- resistant rat aorta. Diabetes, 1999, 48, 2437-45.
40. Cheng JJ, Chao YJ, Wung BS, Wang DL. Cyclic strain-induced plasminogen activator inhibitor-1 (PAI-1) release from endothelial cells involves reactive oxygen species. Biochem Biophys Res Com, 1996, 225, 100-5.
41. Root-Bernstein R, Busik JV, Henry DN. Are diabetic neuropathy, retinopathy and nephropathy caused by hyperglycemic exclusion of dehydroascorbate uptake by glucose transporters? J Theor Biol, 2002, 216, 345-59.
42. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care, 1996, 19, 257-67.
43. Tilton RG. Diabetic vascular dysfunction: links to glucose-induced reductive stress and VEGF. Microsc Res Tech, 2002, 57, 390-407.
44. Spitaler MM, Graier WF. Vascular targets of redox signalling in diabetes mellitus. Diabetologia, 2002, 45, 476-94.
45. Sharpe PC. Liu WH, Yue KKM, et al. Glucose-induced oxidative stress in vascular contractile cells. Comparison of aortic smooth muscle cells and retinal pericytes. Diabetes, 1998, 47, 801-9.
46. Paget C, Lecomte M, Ruggiero D, Wiernsperger N, Lagarde M. Modification of enzymatic antioxidants in retinal microvascular cells by glucose or advanced glycation end products. Free Radic Biol Med, 1998, 25, 121-9.
47. Uemura S, Matsushita H, Li W, Glassford AJ, Asagami T, Lee KH. Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress. Circ Res, 2001, 88, 1291-8.
48. Turk HM, Sevinc A, Camci C, et al. Plasma lipid peroxidation products and antioxidant enzyme activities in patients with type 2 diabetes mellitus. Acta Diabetol, 2002, 39, 117-22.
49. Zobali F, Avci A, Canbolat O, Karasu C. Effects of vitamin A and insulin on the antioxidative state of diabetic rat heart: a comparison study with combination treatment. Cell Biochem Funct, 2002, 20, 75-80.
50. De Zwart LL, Meerman JHN, Commandeur JNM, Vermeulen NPE. Biomarkers of free radical damage applications in experimental animals and in humans. Free Radic Biol Med, 1999, 26, 202-26.
51. Folmer V, Soares JCM, Rocha JBT. Oxidative stress in mice is dependent on the free glucose content of the diet. Int J Biochem Cell Biol, 2002, 34, 1279-85.
52. Ceriello A, Bortolotti N, Motz E, et al. Meal-generated oxidative stress in type 2 diabetic patients. Diabetes Care, 1998, 21, 1529-33.
53. Seghrouchni I, Drai J, Bannier E, et al. Oxidative stress parameters in type I, type II and insulin-treated type 2 diabetes mellitus; insulin treatment efficiency. Clin Chim Acta, 2002, 321,89-96.
54. Dinçer Y, Akçay T, Alademir Z, Ilkova H. Assessment of DNA base oxidation and glutathione level in patients with type 2 diabetes. Mutat Res, 2002, 505, 75-81.
55. Guzik TI, Mussa S, Gastaldi D, et al. Mechanisms of increased vascular superoxide production in human diabetes mellitus. Circulation, 2002, 105, 1656-62.
56. Dominguez C, Ruiz E, Gussinye M, Carrascosa A. Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents. Diabetes Care, 1998, 21, 1736-42.
57. Exposito K, Nappo F, Marfella R, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation, 2002, 106, 2067-72.
58. Tavridou A, Unwin NC, Laker MF, White M, Alberti KGMM. Serum concentrations of vitamin A and E in impaired glucose tolerance. Clin Chim Acta, 1997, 266, 129-40.
59. Niskanen LK, Salonen JT, Nyyssönen K, Uusitupa MIJ. Plasma lipid peroxidation and hyperglycaemia: a connection through hyperinsulinaemia? Diabetic Medicine, 1995, 12, 802-8.
60. Gopaul NK, Manraj MD, Hébé A, et al. Oxidative stress could precede endothelial dysfunction and insulin resistance in Indian Mauritians with impaired glucose metabolism. Diabetologia, 2001, 44, 706-12.
61. Vijayalingam S, Parthiban A, Shanmugasundaram KR, Mohan V. Abnormal antioxidant status in impaired glucose tolerance and non-insulin-dependent diabetes mellitus. Diabetic Medicine, 1996, 13, 715-9.
62. Costa A, Igualá I, Bedini J, Quintó L, Conget I. Uric acid concentration in subjects at risk of type 2 diabetes mellitus: relationship to components of the metabolic síndrome. Metabolism, 2002, 51, 372-5.
63. Ciccone M, Pestrichella V, Rossi O, et al. Oxidative stress is an early marker of endothelial dysfunction. Clin Hemorheol Microcirc, 1999, 21,341-2.
64. 1-3. Am J Clin Nutr, 2000, 72, 776-9.
65. Trevisan M, Browne R, Ram M, et al. Correlates of markers of oxidative status in the general population. Am J Epidemiol, 2001, 348-56.
66. Salonen JT, Nyyssonen K, Tuomainen TP, et al. Increased risk of non-insulin dependent diabetes mellitus at low plasma vitamin E concentrations: a four year follow up study in men. BMJ, 1995, 311, 1124-7.
67. Wiernsperger N. Defects in microvascular haemodynamics during prediabetes contributor of epiphenomenon? Diabetologia, 2000, 43, 1439-48.
68. Laight DW, Desai KM, Änggard EE, Carrier M. Endothelial dysfunction accompanies a pro-oxidant, pro-diabetic challenge in the insulin resistant, obese Zucker rat in vivo. Eur J Pharmacol, 2000, 402, 95-9.
69. Lonn E, Yusuf S, Hoogwerf B, et al. Effects of Vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes. Results of the HOPE study and MICRO-HOPE substudy. Diabetes Care, 2002, 25, 1919-27.
70. Vivekananthan DP, Sapp S, Penn MS. Vitamin E does not reduce mortality or cardiovascular morbidity: a pooled analysis of randomised trials. Circulation, 2002, 106, 3628.
71. Upston JM, Terentis AC, Stocker R. Tocopherol-mediated peroxidation of lipoproteins: implications for vitamin E as a potential antiatherogenic supplement. FASEB J, 1999, 13, 977-94.
72. Denis U, Lecomte M, Paget C, Ruggiero D, Wiernsperger N, Lagarde M. Advanced glycation end-products induce apoptosis of bovine retinal pericytes in culture: involvement of diacylglycero/ceramide production and oxidative stress induction. Free Rad Biol Med, 2002, 33, 236-47.
73. Moini H, Packer L, Saris NE. Antioxidant and prooxidant activities of alpha-lipoic acid and dihydrolipoic acid. Toxicol Appl Pharmacol, 2002, 182, 84-90.
74. Cseko CS, Bagi ZS, Koller A. Modulation of arteriolar myogenic tone by reactive oxygen species. J Vasc Res, 2002, 39, S1: 2
75. Azzi A, Ricciarelli R, Zingg JM. Non-antioxidant molecular functions of α-tocopherol (vitamin E). FEBS Letters, 2002, 519, 8-10.
76. Darko D, Dorhnhorst A, Kelly FJ, Ritter JM, Chowienczyk PJ. Lack of effect of oral vitamin C on blood pressure, oxidative stress and endothelial function in type II diabetes. Clin Sci, 2002, 103, 339-44.
77. Gutteridge JMC, Halliwell B. Free radicals and antioxidants in the year 2000. Ann NY Acad Sci, 2000, 899, 136-47.
78. Barja G. Oxygen radicals, a failure or a success of evolution. Free Radic Res Commun, 1993, 18, 63-70.
79. Mahadev K, Zilbering A, Zhu L, Goldstein BJ. Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1B in vivo and enhances the early insulin action cascade. J Biol Chem, 2001, 276, 21938-42.
80. Laurindo FRM, de Almeida Pedro M, Vieira Barbeiro H, et al. Vascular free radical release. Ex vivo and in vivo evidence for a flow-dependent endothelial mechanism. Circ Res, 1994, 74, 700-9.
81. Kowluru RA, Kennedy A. Therapeutic potential of anti-oxidants and diabetic retinopathy. Expert Opin Investig Drugs, 2001, 10, 1665-76.
82. Cheung MC, Zhao XQ, Chait A, Albers JJ, Brown BG. Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL. Arteroscler Thromb Vasc Biol, 2001, 21, 1320-6.